These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6189902)
1. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. Rosén A; Persson K; Klein G J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients. Lundgren K; Wahlgren M; Troye-Blomberg M; Berzins K; Perlmann H; Perlmann P J Immunol; 1983 Oct; 131(4):2000-3. PubMed ID: 6311902 [TBL] [Abstract][Full Text] [Related]
3. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. Steinitz M; Koskimies S; Klein G; Mäkelä O J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800 [TBL] [Abstract][Full Text] [Related]
4. Construction of human monoclonal antibodies against rabies NS-protein antigen by Epstein-Barr virus transformation. Gebauer W; Lindl T Arzneimittelforschung; 1990 Jun; 40(6):718-22. PubMed ID: 2168706 [TBL] [Abstract][Full Text] [Related]
5. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436 [TBL] [Abstract][Full Text] [Related]
6. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus. Conley ME; Chan MA; Sigal NH J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178 [TBL] [Abstract][Full Text] [Related]
7. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells. Steenbakkers PG; Van Wezenbeek PM; van Zanten J; The TH Hum Antibodies Hybridomas; 1993 Oct; 4(4):166-73. PubMed ID: 7504956 [TBL] [Abstract][Full Text] [Related]
9. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
10. Production of anti-endothelial cell antibodies by coculture of EBV-infected human B cells with endothelial cells. Delneste Y; Lassalle P; Jeannin P; Mannessier L; Dessaint JP; Joseph M; Tonnel AB Cell Immunol; 1993 Aug; 150(1):15-26. PubMed ID: 7688268 [TBL] [Abstract][Full Text] [Related]
11. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines. Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against lipopolysaccharide of Chlamydia trachomatis with cross reactivity to human ApoB. Petyaev IM; Zigangirova NA; Tsibezov VV; Ross A; Bashmakov YK Hybridoma (Larchmt); 2011 Apr; 30(2):131-6. PubMed ID: 21529285 [TBL] [Abstract][Full Text] [Related]
13. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies. Golay JT; Crawford DH Immunology; 1987 Oct; 62(2):279-84. PubMed ID: 2824347 [TBL] [Abstract][Full Text] [Related]
14. Human anti-pneumococci antibody produced by an Epstein Barr virus (EBV)-immortalized cell line. Steinitz M; Tamir S; Goldfarb A J Immunol; 1984 Feb; 132(2):877-82. PubMed ID: 6317751 [TBL] [Abstract][Full Text] [Related]
15. Specificity of monoclonal antibodies to an EBV transformed B-cell line. Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556 [TBL] [Abstract][Full Text] [Related]
16. A human monoclonal antibody to cytomegalovirus (CMV). Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634 [TBL] [Abstract][Full Text] [Related]
17. Human monoclonal anti-Plasmodium falciparum antibodies produced by stable EBV-transformed lymphocytes from patients with falciparum malaria. Khusmith S; Tharavanij S; Chongsa-Nguan M; Tapchaisri P; Sabchareon A; Bunnag D Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):24-32. PubMed ID: 2821629 [TBL] [Abstract][Full Text] [Related]
18. In vitro generated human monoclonal trinitrophenyl-specific B cell lines. Evidence that human and murine anti-trinitrophenyl monoclonal antibodies cross-react with Escherichia coli beta-galactosidase. Golding B; Inghirami G; Peters E; Hoffman T; Balow JE; Tsokos GC J Immunol; 1987 Dec; 139(12):4061-6. PubMed ID: 2826579 [TBL] [Abstract][Full Text] [Related]
19. Specific antigens of Chlamydia pecorum and their homologues in C psittaci and C trachomatis. Baghian A; Kousoulas K; Truax R; Storz J Am J Vet Res; 1996 Dec; 57(12):1720-5. PubMed ID: 8950425 [TBL] [Abstract][Full Text] [Related]
20. [Effect of specific treatment on the evolution of antibody titers against Chlamydia trachomatis measured by the immunofluorescence and complement fixation tests]. Cañada JL; Urkiola MA; Cisterna JR Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):228-30. PubMed ID: 2090210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]